Pubblicazioni

Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study

2023 - FRONTIERS IN ONCOLOGY

Nelli, Fabrizio; Fabbri, Agnese; Botticelli, Andrea; Giannarelli, Diana; Marrucci, Eleonora; Fiore, Cristina; Virtuoso, Antonella; Berrios, Julio Rodrigo Giron; Scagnoli, Simone; Pisegna, Simona; Cirillo, Alessio; Panichi, Valentina; Massari, Annalisa; Silvestri, Maria Assunta; Ruggeri, Enzo Maria

Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study

2023 - FRONTIERS IN ONCOLOGY

B Cell Response Induced by SARS-CoV-2 infection Is boosted by the BNT162b2 vaccine in primary antibody deficiencies

2021 - CELLS

Pulvirenti, Federica; Fernandez Salinas, Ane; Milito, Cinzia; Terreri, Sara; Piano Mortari, Eva; Quintarelli, Concetta; Di Cecca, Stefano; Lagnese, Gianluca; Punziano, Alessandra; Guercio, Marika; Bonanni, Livia; Auria, Stefania; Villani, Francesca; Albano, Christian; Locatelli, Franco; Spadaro, Giuseppe; Carsetti, Rita; Quinti, Isabella